Retour

COMPASS Pathways plc

Qualité des données : 100%

CMPS

NASDAQ Healthcare Medical - Care Facilities

5,22 €

▼ 0,12 € (-2,25%)

Cap. Boursière : 501,13M

Fourchette du Jour

4,88 € 5,31 €

Fourchette 52 Semaines

2,25 € 8,90 €

Volume

2 173 523

Moyenne 50J / 200J

6,89 € / 5,61 €

Clôture Précédente

5,34 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (627 pairs)

Métrique	Action	Médiane du Secteur
P/E	-1,7	0,3
P/B	—	2,9
ROE %	-565,3	3,7
Net Margin %	—	3,8
Rev Growth 5Y %	—	10,0
D/E	—	0,2

Objectif de Cours des Analystes

Hold

18,00 € +244.8%

Low: 15,00 € High: 22,00 €

BPA Prévisionnel

-1,79 €

CA Est.

560000

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2029	0,81 € 0,81 € – 0,81 €	540 M	2
FY2028	-0,83 € -0,83 € – -0,83 €	250 M	3
FY2027	-1,63 € -1,63 € – -1,63 €	43 M	2

Insider Trading Activity

14 transactions

Date	Insider	Type	Shares	Price	Value
Mar 11, 2026	Nath Kabir Chief Executive Officer	other	13 131	6,89 €	90 473 €
Mar 11, 2026	Loxam Teri Chief Financial Officer	other	1 781	6,89 €	12 271 €
Mar 2, 2026	Loxam Teri Chief Financial Officer	other	4 467	7,02 €	31 358 €
Feb 2, 2026	Nath Kabir Chief Executive Officer	other	16 181	6,61 €	106 956 €
Oct 29, 2025	JONAS JEFFREY M Director	grant	52 000	—	—
Aug 1, 2025	Nath Kabir Chief Executive Officer	other	6 366	4,34 €	27 628 €
Jul 29, 2025	Gover Justin D. Director	grant	52 000	—	—
Jun 12, 2025	McQuade Robert Director	grant	26 000	—	—
Jun 12, 2025	SANTINI GINO Director	grant	39 000	—	—
Jun 12, 2025	Jenkins Annalisa Director	grant	26 000	—	—
Jun 12, 2025	Karydas Daphne Director	grant	26 000	—	—
Jun 12, 2025	Norton David Y Director	grant	26 000	—	—
Jun 12, 2025	Lonngren Thomas Director	grant	26 000	—	—
Jun 12, 2025	McGoldrick Linda Director	grant	26 000	—	—

Points Clés

Negative free cash flow of -157,24M

Croissance

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Qualité

Return on Equity

-565,28%

ROICN/A

Net MarginN/A

Op. MarginN/A

Sécurité

Debt / Equity

N/A

Current Ratio0,77

Interest Coverage39,64

Valorisation

P/E Ratio

-1,74

P/B RatioN/A

EV/EBITDAN/A

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	0,0	Net Income (TTM)	-287,86M
ROE	-565,28%	ROA	-136,85%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-157,24M
ROIC	N/A	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	0,77
Interest Coverage	39,64	Dividend Yield	0,00%
Valuation
P/E Ratio	-1,74	P/B Ratio	N/A
P/S Ratio	N/A	PEG Ratio	-0,07
EV/EBITDA	N/A	Dividend Yield	0,00%
Market Cap	501,13M	Enterprise Value	372,45M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	0,0	0,0	0,0	0,0	0,0
Net Income	-287,86M	-155,12M	-118,46M	-91,51M	-71,74M
EPS (Diluted)	-3,08	-2,30	-2,32	-2,16	-1,79
Gross Profit	0,0	0,0	0,0	0,0	0,0
Operating Income	-179,04M	-178,21M	-136,92M	-110,40M	-83,22M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	210,35M	213,67M	275,99M	197,29M	300,90M
Total Liabilities	263,20M	58,97M	50,24M	16,01M	16,49M
Shareholders' Equity	-52,85M	154,70M	225,74M	181,28M	284,41M
Total Debt	20,93M	32,19M	33,05M	1,93M	3,61M
Cash & Equivalents	149,61M	165,08M	220,20M	143,21M	273,24M
Current Assets	191,49M	201,29M	261,30M	191,65M	295,30M
Current Liabilities	247,80M	34,02M	19,60M	15,60M	15,11M